Ultra-processed food, disease activity and inflammation in Ulcerative Colitis: The Manitoba Living with IBD Study

Kathy Vagianos,Casandra Dolovich,Kelcie Witges,Lesley A Graff,Charles N. Bernstein
DOI: https://doi.org/10.14309/ajg.0000000000002667
2024-02-03
The American Journal of Gastroenterology
Abstract:Introduction: To investigate the relationship between ultra-processed food (UPF) consumption and: 1) symptomatic disease and 2) intestinal inflammation among adults with IBD. Methods: We identified participants (Crohn's Disease [CD]; Ulcerative Colitis [UC]) from the Manitoba Living with IBD study. Active disease was defined using the IBD Symptom Inventory (score >14 for CD; >13 for UC); Fecal Calprotectin (FCAL) was measured for intestinal inflammation (>250 ug/g). Diet data were collected using the Harvard Food Frequency Questionnaire. UPF consumption was determined by the NOVA classification system. The percentage of energy consumption from UPFs was calculated and divided into 3 tertiles (T1 = low; T3 = high). Multiple linear regression analysis was used for active disease and inflammation predicted by UPF. Results: Among 135 participants (65% CD), the mean number of episodes of active disease (14.2 vs. 6.21) and active inflammation (1.6 vs 0.6) was significantly higher among UC in the T3 compared to the T1 of UPF consumption (p<0.05). When adjusting for age, gender, disease type and duration, the number of episodes of active disease was lower in the T1 compared to T3 (Beta = -7.11, p = 0.02); similarly, the number of episodes of intestinal inflammation was lower in the T1 (Beta = -0.95, p=0.03). No significant differences were observed among CD. Discussion: UPF consumption may be a predictor of active symptomatic disease and inflammation among UC. Reducing UPF consumption is a dietary strategy that can be suggested for minimizing symptoms and inflammation among people living with IBD.
gastroenterology & hepatology
What problem does this paper attempt to address?